MedTrace Logo

Cetylated Fatty Acid for Reducing Pain After TKA

NCT06300008 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-03-08

No results posted yet for this study

Summary

To compare efficacy of cetylated fatty acid with placebo for reducing postoperative pain after unilateral TKA. The hypothesis is topical cetylated fatty acid can mitigate postoperative pain after TKA.

Conditions

  • Postoperative Pain
  • Postoperative Inflammation

Interventions

DRUG

cetylated fatty acid

use approximately 3 cm long of cream per each side of knee, then apply on the operated knee until completely absorb

DRUG

Placebo

use approximately 3 cm long of cream per each side of knee, then apply on the operated knee until completely absorb

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • Supakit Kanitnate, MD · Thammasat University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06300008 on ClinicalTrials.gov